However, the basal mRNA expression of CCL13 is downregulated in the PBMCs of AD patients, and CCL13 secretion into PBMCs is significantly increased upon stimulation with TLR2 ligands (65). The gene discussed is CCL13; the disease is Alzheimer disease.